40 participants
2nd Line Gemcitabine Monotherapy for Transitional Cell Carcinoma of Urothelium (TCC) After CDDP Regimen
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2007-11-06
- Start Date:
- 2004-01-31
Conditions
- Urologic Neoplasms
- Carcinoma, Transitional Cell
Interventions
- DRUG
No Results Yet